G. Quindós, Epidemiology of candidaemia and invasive candidiasis. A changing face, Revista Iberoamericana de Micolog??a, vol.31, issue.1, pp.42-50, 2014.
DOI : 10.1016/j.riam.2013.10.001

M. Pfaller and D. Diekema, Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-63, 2007.
DOI : 10.1128/CMR.00029-06

M. Cuenca-estrella, P. Verweij, M. Arendrup, S. Arikan-akdagli, J. Bille et al., ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures, Clinical Microbiology and Infection, vol.18, pp.9-18, 2012.
DOI : 10.1111/1469-0691.12038

N. Halkic and R. Ksontini, Hepatosplenic Candidiasis, New England Journal of Medicine, vol.356, issue.4, p.4, 2007.
DOI : 10.1056/NEJMicm040112

A. Ullmann, M. Akova, R. Herbrecht, C. Viscoli, M. Arendrup et al., ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT), Clinical Microbiology and Infection, vol.18, pp.53-67, 2012.
DOI : 10.1111/1469-0691.12041

A. Ullmann, O. Cornely, J. Donnelly, M. Akova, M. Arendrup et al., ESCMID* *Information in this manuscript was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases, Clinical Microbiology and Infection, vol.18, pp.1-8, 2012.
DOI : 10.1111/1469-0691.12037

B. Sendid, M. Tabouret, J. Poirot, D. Mathieu, J. Fruit et al., New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis, J Clin Microbiol. mai, vol.37, issue.5, pp.1510-1517, 1999.

H. Yera, B. Sendid, N. Francois, D. Camus, and D. Poulain, Contribution of Serological Tests and Blood Culture to the Early Diagnosis of Systemic Candidiasis, European Journal of Clinical Microbiology and Infectious Diseases, vol.20, issue.12, pp.864-70, 2001.
DOI : 10.1007/s100960100629

M. Mikulska, C. T. Sanguinetti, M. Poulain, D. Viscoli, and C. , The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia, Critical Care, vol.14, issue.6, p.222, 2010.
DOI : 10.1128/CVI.00200-08

URL : https://hal.archives-ouvertes.fr/inserm-00663709

D. Thompson, P. Carlisle, and D. Kadosh, ABSTRACT, Eukaryotic Cell, vol.10, issue.9, pp.1173-82, 2011.
DOI : 10.1128/EC.05085-11

P. Sudbery, N. Gow, and J. Berman, The distinct morphogenic states of Candida albicans, Trends in Microbiology, vol.12, issue.7, pp.317-341, 2004.
DOI : 10.1016/j.tim.2004.05.008

D. Chabasse, J. Bouchara, N. Contet-audonneau, and A. Basile, Moisissures, dermatophytes, levures: du prélèvement au diagnostic. Biomérieux. Marcy-l, 0190.

J. Bouchara, M. Pihet, D. Gentile, L. Cimon, B. Chabasse et al., Les levures et levuroses, Bioforma, 0200.

M. Develoux and S. Bretagne, Candidoses et levuroses diverses, EMC -Mal Infect. sept, vol.2, issue.3, pp.119-158, 2005.
DOI : 10.1016/j.emcmi.2005.04.001

P. Eggimann and D. Pittet, Candidémie et candidose généralisée. EMC -Anesth- Réanimation, janv, vol.7, issue.1, pp.1-25, 2010.

M. Nucci and E. Anaissie, Revisiting the Source of Candidemia: Skin or Gut?, Clinical Infectious Diseases, vol.32, issue.12, 2001.
DOI : 10.1016/S0002-9343(98)00030-8

J. Delaloye and C. T. , Invasive candidiasis as a cause of sepsis in the critically ill patient, Virulence, vol.37, issue.1, pp.161-170, 2014.
DOI : 10.1111/1469-0691.12039

P. Eggimann and D. Pittet, Candidoses en r??animationCandidiasis and intensive care patients., R??animation, vol.11, issue.3, pp.209-230, 2002.
DOI : 10.1016/S1624-0693(02)00233-5

D. Soll, Candida commensalism and virulence: the evolution of phenotypic plasticity, Acta Tropica, vol.81, issue.2, pp.101-111, 2002.
DOI : 10.1016/S0001-706X(01)00200-5

C. Kumamoto and M. Vinces, Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence, Cellular Microbiology, vol.64, issue.11, pp.1546-54, 2005.
DOI : 10.1111/j.1462-5822.2005.00616.x

R. Calderone and W. Fonzi, Virulence factors of Candida albicans, Trends in Microbiology, vol.9, issue.7, pp.327-362, 2001.
DOI : 10.1016/S0966-842X(01)02094-7

L. Douglas, Candida biofilms and their role in infection, Trends in Microbiology, vol.11, issue.1, pp.30-36, 2003.
DOI : 10.1016/S0966-842X(02)00002-1

L. Romani, Immunity to Candida albicans: Th1, Th2 cells and beyond, Current Opinion in Microbiology, vol.2, issue.4, pp.363-370, 1999.
DOI : 10.1016/S1369-5274(99)80064-2

L. Romani, A. Mencacci, E. Cenci, P. Puccetti, and F. Bistoni, Neutrophils and the adaptive immune response to Candida albicans, Research in Immunology, vol.147, issue.8-9, pp.512-520, 1996.
DOI : 10.1016/S0923-2494(97)85216-9

A. Casadevall, Antibody immunity and invasive fungal infections, Infect Immun. janv, vol.63, issue.11, pp.4211-4219, 1995.

S. Shoham and S. Levitz, The immune response to fungal infections, British Journal of Haematology, vol.64, issue.2, pp.569-82, 2005.
DOI : 10.1128/IAI.72.9.5373-5382.2004

L. Romani, Innate and adaptive immunity in Candida albicans infections and saprophytism, J Leukoc Biol. janv, vol.68, issue.2, pp.175-184, 2000.

M. Pfaller, G. Moet, S. Messer, R. Jones, and M. Castanheira, ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, pp.561-567, 2008.
DOI : 10.1128/AAC.01079-10

R. Wenzel and M. Edmond, The Impact of Hospital-Acquired Bloodstream Infections, Emerging Infectious Diseases, vol.7, issue.2, pp.174-181, 2001.
DOI : 10.3201/eid0702.010203

A. Tortorano, C. Kibbler, J. Peman, H. Bernhardt, L. Klingspor et al., Candidaemia in Europe: epidemiology and resistance, International Journal of Antimicrobial Agents, vol.27, issue.5, pp.359-66, 2006.
DOI : 10.1016/j.ijantimicag.2006.01.002

D. Toubas, Epidémiologie des candidoses invasives. Rev Francoph Lab, mars, vol.2013, issue.450, pp.27-36, 2013.
DOI : 10.1016/s1773-035x(13)71944-0

G. Martin, D. Mannino, S. Eaton, and M. Moss, The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 2000.
DOI : 10.1056/NEJMoa022139

C. Lass-flörl, The changing face of epidemiology of invasive fungal disease in Europe, Mycoses, vol.11, issue.3, pp.197-205, 2009.
DOI : 10.1099/0022-1317-51-8-677

M. Nucci, F. Queiroz-telles, A. Tobón, A. Restrepo, and A. Colombo, Epidemiology of Opportunistic Fungal Infections in Latin America, Clinical Infectious Diseases, vol.51, issue.5, pp.561-70, 2010.
DOI : 10.1086/655683

R. Grillot, Numéro thématique?Mycoses invasives en France: épidémiologie, enjeux diagnostiques et thérapeutiques. BEH -Bull Épidémiologique Hebd, avr, vol.2013, pp.12-13107, 2013.

M. Arendrup, Candida and candidaemia. Susceptibility and epidemiology, Dan Med J. nov, vol.60, issue.11, p.4698, 2013.

M. Pfaller, M. Castanheira, S. Messer, G. Moet, and R. Jones, Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program, 2008.

G. Caggiano, R. Iatta, A. Laneve, F. Manca, and M. Montagna, Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004, Mycoses, vol.86, issue.2, pp.123-131, 1998.
DOI : 10.1007/s001340050552

O. Leroy, J. Gangneux, P. Montravers, J. Mira, F. Gouin et al., Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005???2006), Critical Care Medicine, vol.37, issue.5, pp.1612-1620, 2005.
DOI : 10.1097/CCM.0b013e31819efac0

URL : https://hal.archives-ouvertes.fr/hal-00676319

C. Moran, C. Grussemeyer, J. Spalding, B. Jr, . Dk et al., Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections, American Journal of Infection Control, vol.38, issue.1, pp.78-80, 2010.
DOI : 10.1016/j.ajic.2009.06.014

A. Alanio, C. Renaudat, and S. Bretagne, ??pid??miologie de la r??sistance des champignons??: impact de nos prescriptions d???antifongiques, Journal des Anti-infectieux, vol.16, issue.1, pp.2-7, 2014.
DOI : 10.1016/j.antinf.2014.01.006

P. Fournier, C. Schwebel, D. Maubon, A. Vesin, B. Lebeau et al., Antifungal use influences Candida species distribution and susceptibility in the intensive care unit, Journal of Antimicrobial Chemotherapy, vol.171, issue.2, pp.2880-2886, 2011.
DOI : 10.1007/s11046-010-9369-3

URL : https://hal.archives-ouvertes.fr/hal-00818509

D. Pittet, M. Monod, P. Suter, E. Frenk, and R. Auckenthaler, Candida Colonization and Subsequent Infections in Critically III Surgical Patients, Annals of Surgery, vol.220, issue.6, pp.751-759, 1994.
DOI : 10.1097/00000658-199412000-00008

P. Eggimann and D. Pittet, Candida colonization index and subsequent infection in critically ill surgical patients: 20??years later, Intensive Care Medicine, vol.42, issue.Suppl 7, pp.1429-1477, 2014.
DOI : 10.1097/CCM.0000000000000208

B. Dubau, C. Triboulet, and S. Winnock, Utilisation pratique de l??index de colonisation, Annales Fran??aises d'Anesth??sie et de R??animation, vol.20, issue.4, pp.418-438, 2001.
DOI : 10.1016/S0750-7658(01)00375-6

C. León, S. Ruiz-santana, P. Saavedra, B. Almirante, J. Nolla-salas et al., A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*, Critical Care Medicine, vol.34, issue.3, pp.730-737, 2006.
DOI : 10.1097/01.CCM.0000202208.37364.7D

C. León, S. Ruiz-santana, P. Saavedra, B. Galván, A. Blanco et al., Usefulness of the ???Candida score??? for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study, Critical Care Medicine, vol.37, issue.5, pp.1624-1657, 2009.
DOI : 10.1097/CCM.0b013e31819daa14

P. Eggimann and D. Pittet, Candidoses du sujet non neutropénique : de la colonisation à l'infection. Ann Fr Anesth Réanimation, avr, vol.20, issue.4, pp.382-390, 2001.
DOI : 10.1016/s0750-7658(01)00374-4

A. Lefort, L. Chartier, B. Sendid, M. Wolff, J. Mainardi et al., Diagnosis, management and outcome of Candida endocarditis, Clinical Microbiology and Infection, vol.18, issue.4, pp.99-109, 2012.
DOI : 10.1111/j.1469-0691.2012.03764.x

J. Fisher, Candida Urinary Tract Infections???Epidemiology, Pathogenesis, Diagnosis, and Treatment: Executive Summary, Clinical Infectious Diseases, vol.29, issue.Suppl 3, pp.429-461, 2011.
DOI : 10.1086/598658

T. Fraisse, L. Lachaud, A. Sotto, J. Lavigne, G. Cariou et al., Recommandations du comit?? d???infectiologie de l???AFU. Diagnostic, traitement et suivi des candiduries, Progr??s en Urologie, vol.21, issue.5, pp.314-335, 2011.
DOI : 10.1016/j.purol.2011.02.004

A. Sellami, H. Sellami, F. Makni, M. Bahloul, F. Cheikh-rouhou et al., La candidurie en??milieu de??r??animation??: signification et??int??r??t de??la??num??ration des??levures dans??les??urines, Annales Fran??aises d'Anesth??sie et de R??animation, vol.25, issue.6, pp.584-592, 2006.
DOI : 10.1016/j.annfar.2006.02.019

M. Pihet and A. Marot, Diagnostic biologique des candidoses. Rev Francoph Lab, mars, vol.2013, issue.450, pp.47-61, 2013.
DOI : 10.1016/s1773-035x(13)71946-4

S. Brun, J. Bouchara, and D. Chabasse, Diagnostic au laboratoire des mycoses profondes. Rev Fr Lab, janv, issue.359, pp.33-41, 2004.
DOI : 10.1016/s0338-9898(04)90075-3

C. Kauffmann-lacroix, M. Albouy-llaty, V. Migeot, and N. Contet-audonneau, Enqu??te sur les conditions analytiques d???un examen de mycologie m??dicale aupr??s des membres de la Soci??t?? fran??aise de mycologie m??dicale, Journal de Mycologie M??dicale, vol.21, issue.3, pp.159-68, 2011.
DOI : 10.1016/j.mycmed.2011.05.003

D. Chabasse and N. Contet-audonneau, Examen direct et place de l'histologie en mycologie. Rev Fr Lab, pp.49-54, 2003.
DOI : 10.1016/s0338-9898(03)90059-x

A. Michel-nguyen, A. Favel, and P. Regli, Identification des levures au laboratoire: Comment allier performance et simplicité, Feuill Biol, vol.43, issue.245, pp.41-52, 2002.

J. Pemán and R. Zaragoza, Current diagnostic approaches to invasive candidiasis in critical care settings, Mycoses, vol.177, issue.Suppl. 3, pp.424-457, 2010.
DOI : 10.1016/S0213-005X(04)73039-6

F. Odds and R. Bernaerts, CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species, J Clin Microbiol. août, vol.32, issue.8, pp.1923-1932, 1994.

A. Gaschet, L. Ollivier, C. Laplanche, A. Vagner, O. Dalle et al., Evaluation of CandiSelect4, a new chromogenic medium for isolation and presumptive identification of Candida species from clinical specimens, Journal de Mycologie M??dicale, vol.18, issue.2, pp.89-95, 2008.
DOI : 10.1016/j.mycmed.2008.04.004

B. Willinger, C. Hillowoth, B. Selitsch, and M. Manafi, Performance of Candida ID, a New Chromogenic Medium for Presumptive Identification of Candida Species, in Comparison to CHROMagar Candida, Journal of Clinical Microbiology, vol.39, issue.10, pp.3793-3798, 2001.
DOI : 10.1128/JCM.39.10.3793-3795.2001

J. D. Perry and A. Freydière, The application of chromogenic media in clinical microbiology, Journal of Applied Microbiology, vol.3, issue.6, pp.2046-55, 2007.
DOI : 10.1111/j.1365-2672.2006.03096.x

D. Pincus, S. Orenga, and S. Chatellier, Yeast identification ??? past, present, and future methods, Medical Mycology, vol.3, issue.1, pp.97-121, 2007.
DOI : 10.1016/S1567-1356(03)00012-6

URL : https://academic.oup.com/mmy/article-pdf/45/2/97/4050698/45-2-97.pdf

V. Letscher-bru, M. Meyer, A. Galoisy, J. Waller, and E. Candolfi, Prospective Evaluation of the New Chromogenic Medium Candida ID, in Comparison with Candiselect, for Isolation of Molds and Isolation and Presumptive Identification of Yeast Species, Journal of Clinical Microbiology, vol.40, issue.4, pp.1508-1518, 2002.
DOI : 10.1128/JCM.40.4.1508-1510.2002

M. Pfaller, A. Houston, and S. Coffmann, Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata, J Clin Microbiol. janv, vol.34, issue.1, pp.58-61, 1996.

M. Jabra-rizk, T. Brenner, M. Romagnoli, A. A. Baqui, . Ma et al., Evaluation of a Reformulated CHROMagar Candida, Journal of Clinical Microbiology, vol.39, issue.5, pp.2015-2021, 2001.
DOI : 10.1128/JCM.39.5.2015-2016.2001

H. Powell, C. Sand, and R. Rennie, Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species, Diagnostic Microbiology and Infectious Disease, vol.32, issue.3, pp.201-205, 1998.
DOI : 10.1016/S0732-8893(98)00096-0

G. Quindós, S. Millan, R. Bikandi, J. Pontón, and J. , Utility of Fluoroplate Candida for the rapid identification of Candida albicans, Enfermedades Infecc Microbiol Clínica. déc, vol.14, issue.10, pp.586-595, 1996.

P. Rousselle, A. Freydiere, P. Couillerot, H. Montclos, . De et al., Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates, J Clin Microbiol. déc, vol.32, issue.12, p.3034, 1994.
URL : https://hal.archives-ouvertes.fr/hal-00313094

L. Ostrosky-zeichner, Invasive Mycoses: Diagnostic Challenges, The American Journal of Medicine, vol.125, issue.1, pp.14-24, 2012.
DOI : 10.1016/j.amjmed.2011.10.008

J. Fernandez, B. Erstad, W. Petty, and D. Nix, Time to positive culture and identification for Candida blood stream infections, Diagnostic Microbiology and Infectious Disease, vol.64, issue.4, pp.402-409, 2009.
DOI : 10.1016/j.diagmicrobio.2009.04.002

D. Pauw, B. Walsh, T. Donnelly, J. Stevens, D. Edwards et al., Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.285, issue.12, pp.1813-1834, 2008.
DOI : 10.1086/518852

J. Berenguer, M. Buck, F. Witebsky, F. Stock, P. Pizzo et al., Lysis???centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection, Diagnostic Microbiology and Infectious Disease, vol.17, issue.2, pp.103-112, 1993.
DOI : 10.1016/0732-8893(93)90020-8

M. Meyer, V. Letscher-bru, B. Jaulhac, J. Waller, and E. Candolfi, Comparison of Mycosis IC/F and Plus Aerobic/F Media for Diagnosis of Fungemia by the Bactec 9240 System, Journal of Clinical Microbiology, vol.42, issue.2, pp.773-780, 2004.
DOI : 10.1128/JCM.42.2.773-777.2004

. Becton-dickinson, BD (Becton, Dickinson and Company) -Diagnostic Systems: BD BACTEC TM Instrumented Blood Culture Systems

. Biomérieux and . Bact, ALERT 3D Microbial Detection Systems Overview | bioMérieux Clinical Diagnostics [En ligne]. (consulté le 24 janv 2015) Disponible sur: http://www.biomerieux-diagnostics.com/bact-alert-3d-microbial-detection-systems- overview

L. Horvath, D. Hospenthal, C. Murray, and D. Dooley, Detection of Simulated Candidemia by the BACTEC 9240 System with Plus Aerobic/F and Anaerobic/F Blood Culture Bottles, Journal of Clinical Microbiology, vol.41, issue.10, pp.4714-4721, 2003.
DOI : 10.1128/JCM.41.10.4714-4717.2003

S. Mirrett, L. Reller, C. Petti, C. Woods, B. Vazirani et al., Controlled Clinical Comparison of BacT/ALERT Standard Aerobic Medium with BACTEC Standard Aerobic Medium for Culturing Blood, Journal of Clinical Microbiology, vol.41, issue.6, pp.2391-2395, 2003.
DOI : 10.1128/JCM.41.6.2391-2394.2003

L. Horvath, B. George, C. Murray, L. Harrison, and D. Hospenthal, Direct Comparison of the BACTEC 9240 and BacT/ALERT 3D Automated Blood Culture Systems for Candida Growth Detection, Journal of Clinical Microbiology, vol.42, issue.1, pp.115-123, 2004.
DOI : 10.1128/JCM.42.1.115-118.2004

L. Klingspor, S. Muhammed, and V. Ozenci, Comparison of the two blood culture systems, Bactec 9240 and BacT/Alert 3D, in the detection of Candida spp. and bacteria with polymicrobial sepsis, European Journal of Clinical Microbiology & Infectious Diseases, vol.72, issue.11, pp.2983-2990, 2012.
DOI : 10.1016/j.diagmicrobio.2011.12.012

C. Hennequin, R??le du laboratoire dans le diagnostic et la pr??vention des infections fongiques, Annales Fran??aises d'Anesth??sie et de R??animation, vol.20, issue.4, pp.407-419, 2001.
DOI : 10.1016/S0750-7658(01)00372-0

D. Sullivan and D. Coleman, Candida dubliniensis: Characteristics and Identification, J Clin Microbiol. févr, vol.36, issue.2, p.329, 1998.

G. Quindos, S. Millan, R. Robert, R. Bernard, C. Ponton et al., Evaluation of bichro-latex albicans, a new method for rapid identification of Candida albicans, J Clin Microbiol. mai, vol.35, issue.5, pp.1263-1268, 1997.

P. Cahen, F. Laurent, P. Honderlick, and F. Saheb, Utilization of Bichrolatex albicans test for the rapid identification of Candida albicans in blood culture bottles in fungemia: preliminary results from a multicenter study, Pathol Biol, vol.47, issue.5, pp.512-516, 1999.

A. Freydiere, L. Buchaille, R. Guinet, and Y. Gille, Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies, J Clin Microbiol. janv, vol.35, issue.4, pp.877-80, 1997.

R. Grillot, Les Mycoses humaines : démarche diagnostique, 1996.

A. Freydiere, R. Robert, C. Ploton, A. Marot-leblond, F. Monerau et al., Rapid identification of Candida glabrata with a new commercial test

D. Hata, L. Hall, A. Fothergill, D. Larone, and N. Wengenack, Multicenter Evaluation of the New VITEK 2 Advanced Colorimetric Yeast Identification Card, Journal of Clinical Microbiology, vol.45, issue.4, pp.1087-92, 2007.
DOI : 10.1128/JCM.01754-06

S. Günde?, S. Gulenc, and R. Bingol, Comparative performance of Fungichrom I, Candifast and API 20C Aux systems in the identification of clinically significant yeasts, Journal of Medical Microbiology, vol.50, issue.12, pp.1105-1115, 2001.
DOI : 10.1099/0022-1317-50-12-1105

G. Valenza, J. Strasen, F. Schäfer, M. Frosch, O. Kurzai et al., Evaluation of New Colorimetric Vitek 2 Yeast Identification Card by Use of Different Source Media, Journal of Clinical Microbiology, vol.46, issue.11, pp.3784-3791, 2008.
DOI : 10.1128/JCM.01318-08

O. Bader, MALDI-TOF-MS-based species identification and typing approaches in medical mycology, PROTEOMICS, vol.49, issue.Suppl 1, pp.788-99, 2013.
DOI : 10.1128/JCM.00339-11

A. Alanio, La spectrom??trie de masse de type MALDI-TOF en mycologie clinique??: avantages r??els, ??cueils potentiels, Journal des Anti-infectieux, vol.15, issue.2, pp.71-82, 2013.
DOI : 10.1016/j.antinf.2013.04.001

C. Lacroix, A. Gicquel, B. Sendid, J. Meyerd, I. Accoceberry et al., Identification des levures du genre Candida par spectrom??trie de masse de type MALDI-TOF??: comparaison des syst??mes Andromas ?? et Bruker/Biotyper v.2 ??, Journal de Mycologie M??dicale, vol.22, issue.1, p.107, 2012.
DOI : 10.1016/j.mycmed.2011.12.028

O. Bader, M. Weig, L. Taverne-ghadwal, R. Lugert, U. Gross et al., Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Clinical Microbiology and Infection, vol.17, issue.9, pp.1359-65, 2011.
DOI : 10.1111/j.1469-0691.2010.03398.x

T. Spanu, B. Posteraro, B. Fiori, D. Inzeo, T. Campoli et al., Direct MALDI-TOF Mass Spectrometry Assay of Blood Culture Broths for Rapid Identification of Candida Species Causing Bloodstream Infections: an Observational Study in Two Large Microbiology Laboratories, Journal of Clinical Microbiology, vol.50, issue.1, pp.176-185, 2012.
DOI : 10.1128/JCM.05742-11

N. Dhiman, L. Hall, S. Wohlfiel, S. Buckwalter, and N. Wengenack, Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Routine Identification of Yeast, Journal of Clinical Microbiology, vol.49, issue.4, pp.1614-1620, 2011.
DOI : 10.1128/JCM.02381-10

M. Bougnoux and F. Espinasse, Nouvelles applications des techniques de biologie moléculaire en mycologie médicale. Rev Fr Lab, pp.67-71, 2003.
DOI : 10.1016/s0338-9898(03)73391-5

G. Kofla and M. Ruhnke, Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression, Journal of Microbiological Methods, vol.68, issue.1, pp.178-83, 2007.
DOI : 10.1016/j.mimet.2006.07.011

E. Cendejas-bueno, A. Gomez-lopez, E. Mellado, J. Rodriguez-tudela, and M. Cuenca-estrella, Identification of Pathogenic Rare Yeast Species in Clinical Samples: Comparison between Phenotypical and Molecular Methods, Journal of Clinical Microbiology, vol.48, issue.5, pp.1895-1904, 2010.
DOI : 10.1128/JCM.00336-10

L. Hall, L. Febre, K. Deml, S. Wohlfiel, S. Wengenack et al., Evaluation of the Yeast Traffic Light PNA FISH Probes for Identification of Candida Species from Positive Blood Cultures, Journal of Clinical Microbiology, vol.50, issue.4, pp.1446-1454, 2012.
DOI : 10.1128/JCM.06148-11

N. Stone, R. Gorton, K. Barker, P. Ramnarain, and C. Kibbler, Evaluation of PNA-FISH Yeast Traffic Light for Rapid Identification of Yeast Directly from Positive Blood Cultures and Assessment of Clinical Impact, Journal of Clinical Microbiology, vol.51, issue.4, pp.1301-1303, 2013.
DOI : 10.1128/JCM.00028-13

S. Hanna, A. Blancard, J. Roziere, H. Dumon, and J. Manelli, Diagnostic des candidémies par PCR nichée et comparaison avec les hémocultures, J Mycol Médicale. juin, vol.13, issue.2, pp.61-67, 2003.

R. Mcmullan, L. Metwally, P. Coyle, S. Hedderwick, B. Mccloskey et al., A Prospective Clinical Trial of a Real-Time Polymerase Chain Reaction Assay for the Diagnosis of Candidemia in Nonneutropenic, Critically Ill Adults, Clinical Infectious Diseases, vol.34, issue.1, pp.890-896, 2008.
DOI : 10.1086/323335

A. Lau, C. Halliday, S. Chen, E. Playford, K. Stanley et al., Comparison of Whole Blood, Serum, and Plasma for Early Detection of Candidemia by Multiplex-Tandem PCR, Journal of Clinical Microbiology, vol.48, issue.3, pp.811-817, 2010.
DOI : 10.1128/JCM.01650-09

T. Avni, L. Leibovici, and M. Paul, PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis, Journal of Clinical Microbiology, vol.49, issue.2, pp.665-70, 2011.
DOI : 10.1128/JCM.01602-10

F. Wallet, S. Nseir, L. Baumann, S. Herwegh, B. Sendid et al., Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood, Clinical Microbiology and Infection, vol.16, issue.6, pp.774-783, 2010.
DOI : 10.1111/j.1469-0691.2009.02940.x

D. Karageorgopoulos, E. Vouloumanou, F. Ntziora, A. Michalopoulos, P. Rafailidis et al., ??-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis, Clinical Infectious Diseases, vol.44, issue.17, pp.750-70, 2011.
DOI : 10.1128/AAC.00658-06

B. Posteraro, D. Pascale, G. Tumbarello, M. Torelli, R. Pennisi et al., Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1???3)-??-D-glucan assay, Candida score, and colonization index, Critical Care, vol.15, issue.5, p.249, 2011.
DOI : 10.1007/s10096-004-1104-x

F. Lamoth, M. Cruciani, C. Mengoli, E. Castagnola, O. Lortholary et al., ??-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3), Third European Conference on Infections in Leukemia (ECIL-3), pp.633-676, 2012.
DOI : 10.1086/496927

S. Bretagne, Antig??nes fongiques en??r??animation: tests??disponibles et????tat des??lieux, R??animation, vol.16, issue.3, pp.232-241, 2007.
DOI : 10.1016/j.reaurg.2007.02.016

S. Anane and F. Khalfallah, Diagnostic biologique des??candidoses syst??miques??: difficult??s et??perspectives, Pathologie Biologie, vol.55, issue.5, pp.262-72, 2007.
DOI : 10.1016/j.patbio.2006.03.003

R. Zaragoza, J. Pemán, G. Quindós, J. Iruretagoyena, M. Cuétara et al., Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients, Clinical Microbiology and Infection, vol.15, issue.6, pp.592-597, 2009.
DOI : 10.1111/j.1469-0691.2009.02794.x

J. Pemán, R. Zaragoza, G. Quindós, M. Alkorta, M. Cuétara et al., Clinical factors associated with a Candida albicansGerm Tube Antibody positive test in Intensive Care Unit patients, BMC Infectious Diseases, vol.34, issue.1, p.60, 2011.
DOI : 10.1097/01.CCM.0000202435.98240.ED

V. Letscher-bru, Antifongigramme et concentration minimale inhibitrice -EM|Premium, EMC -Biol Médicale, vol.1, issue.7, 2011.
DOI : 10.1016/s2211-9698(11)71450-9

A. Datry, J. Carriere, L. Pitre, M. Groussin, H. Silberstien et al., Analyse critique des tests de sensibilit?? in vitro aux antifongiques, M??decine et Maladies Infectieuses, vol.25, pp.6-13, 1995.
DOI : 10.1016/S0399-077X(05)81245-4

J. Rex, L. Clinical, and . Standards-institute, Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard M27-A3-3rd Ed, 2008.

J. Rex, L. Clinical, and . Standards-institute, Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard M38-A2, 2008.

M. Pfaller, A. Espinel-ingroff, L. Boyken, R. Hollis, J. Kroeger et al., Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values, Journal of Clinical Microbiology, vol.49, issue.3, pp.845-50, 2011.
DOI : 10.1128/JCM.02441-10

A. Espinel-ingroff, M. Pfaller, B. Bustamante, E. Canton, A. Fothergill et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.58, issue.4, 2014.
DOI : 10.1128/AAC.02615-13

M. Cuenca-estrella, W. Lee-yang, M. Ciblak, B. Arthington-skaggs, E. Mellado et al., Comparative Evaluation of NCCLS M27-A and EUCAST Broth Microdilution Procedures for Antifungal Susceptibility Testing of Candida Species, Antimicrobial Agents and Chemotherapy, vol.46, issue.11, pp.3644-3651, 2002.
DOI : 10.1128/AAC.46.11.3644-3647.2002

A. Espinel-ingroff, F. Barchiesi, M. Cuenca-estrella, M. Pfaller, M. Rinaldi et al., International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole, Journal of Clinical Microbiology, vol.43, issue.8, pp.3884-3893, 2005.
DOI : 10.1128/JCM.43.8.3884-3889.2005

M. Pfaller, M. Castanheira, D. Diekema, S. Messer, G. Moet et al., Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species, Journal of Clinical Microbiology, vol.48, issue.5, pp.1592-1601, 2010.
DOI : 10.1128/JCM.02445-09

M. Cuenca-estrella, A. Gomez-lopez, E. Mellado, and J. Rodriguez-tudela, Correlation between the procedure for antifungal susceptibility testing for Candida spp, of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques, pp.486-92, 2005.

M. Pfaller, D. Diekema, G. Procop, and N. Wiederhold, Multicenter Evaluation of the New Vitek 2 Yeast Susceptibility Test Using New CLSI Clinical Breakpoints for Fluconazole, Journal of Clinical Microbiology, vol.52, issue.6, pp.2126-2156, 2014.
DOI : 10.1128/JCM.00658-14

A. Espinel-ingroff, M. Pfaller, S. Messer, C. Knapp, N. Holliday et al., Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 Reference Method for Testing New Antifungal Agents against Clinical Isolates of Candida spp., Journal of Clinical Microbiology, vol.42, issue.2, pp.718-739, 2004.
DOI : 10.1128/JCM.42.2.718-721.2004

K. Davey, A. Holmes, E. Johnson, A. Szekely, and D. Warnock, Comparative Evaluation of FUNGITEST and Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Candida Species and Cryptococcus neoformans, J Clin Microbiol. avr, vol.36, issue.4, pp.926-956, 1998.

M. Cuenca-estrella, A. Gomez-lopez, A. Alastruey-izquierdo, L. Bernal-martinez, I. Cuesta et al., Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates, Journal of Clinical Microbiology, vol.48, issue.5, p.17826, 2010.
DOI : 10.1128/JCM.02316-09

N. Bourgeois, L. Dehandschoewercker, S. Bertout, P. Bousquet, P. Rispail et al., spp. Isolated Primarily during Invasive Candidiasis and Comparison of the Vitek 2 System with the CLSI Broth Microdilution and Etest Methods, Journal of Clinical Microbiology, vol.48, issue.1, pp.154-61, 2010.
DOI : 10.1128/JCM.01096-09

A. Espinel-ingroff, E. Canton, D. Gibbs, and A. Wang, Correlation of Neo-Sensitabs Tablet Diffusion Assay Results on Three Different Agar Media with CLSI Broth Microdilution M27-A2 and Disk Diffusion M44-A Results for Testing Susceptibilities of Candida spp. and Cryptococcus neoformans to Amphotericin B, Caspofungin, Fluconazole, Itraconazole, and Voriconazole, Journal of Clinical Microbiology, vol.45, issue.3, pp.858-64, 2007.
DOI : 10.1128/JCM.01900-06

J. Rex, M. Pfaller, J. Galgiani, M. Bartlett, A. Espinel-ingroff et al., Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections, Clinical Infectious Diseases, vol.24, issue.2, pp.235-282, 1997.
DOI : 10.1093/clinids/24.2.235

J. Rex and M. Pfaller, Has Antifungal Susceptibility Testing Come of Age?, Clinical Infectious Diseases, vol.12, issue.8, pp.982-991, 2002.
DOI : 10.1016/S0924-8579(01)00363-6

E. Dannaoui, D??finitions actuelles??: ????breakpoints-epidemiological cut-off????, Journal de Mycologie M??dicale, vol.23, issue.1, p.70, 2013.
DOI : 10.1016/j.mycmed.2012.12.007

F. Granier, Antifongiques: classes thérapeutiques, mécanismes d'action, problèmes de résistance, Antibiotiques. févr, vol.5, issue.1, pp.39-48, 2003.

. Disponible-sur, sfar.org/article/247/prise-en-charge-des-candidoses-et-aspergilloses- invasives-de-l-rsquo-adulte-cc, 2004.

A. Bryskier, Antibiotiques, agents antibactériens et antifongiques. Paris: Ellipses Editions Marketing, 1999.

F. Taieb, F. Méchaï, A. Lefort, F. Lanternier, M. Bougnoux et al., Prise en charge des infections syst??miques ?? Candida spp., Prise en charge des infections systémiques à Candida spp, pp.173-80, 2011.
DOI : 10.1016/j.revmed.2010.08.019

E. Andrès, M. Tiphine, V. Letscher-bru, and R. Herbrecht, Nouvelles formes lipidiques de l???amphot??ricine??B. Revue de la litt??rature, La Revue de M??decine Interne, vol.22, issue.2, pp.141-50, 2001.
DOI : 10.1016/S0248-8663(00)00304-0

M. Moen, K. Lyseng-williamson, and L. Scott, Liposomal Amphotericin B, Drugs, vol.24, issue.6, pp.361-92, 2009.
DOI : 10.7326/0003-4819-137-2-200207160-00008

F. Lanternier and O. Lortholary, Liposomal amphotericin B: what is its role in, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. mai, vol.14, issue.4, pp.71-83, 2008.

A. Kettani, Z. Belkhadir, A. Mosadik, M. Faroudy, A. Ababou et al., Traitement antifongique des??candidoses syst??miques en??r??animation, Journal de Mycologie M??dicale, vol.16, issue.1, pp.16-25, 2006.
DOI : 10.1016/j.mycmed.2005.10.004

H. Dupont, Levures en réanimation. Congrès national d'anesthésie et de réanimation, Les Essentiels, 2007.

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, . Jr et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009.
DOI : 10.1086/596757

B. Guery, M. Arendrup, G. Auzinger, E. Azoulay, B. Sá et al., Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis, Intensive Care Medicine, vol.46, issue.1, pp.55-62, 2009.
DOI : 10.1016/S0213-005X(04)73039-6

J. Nolla-salas, A. Sitges-serra, C. León-gil, J. Martínez-gonzález, M. León-regidor et al., Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy, Intensive Care Medicine, vol.23, issue.1, pp.23-30, 1997.
DOI : 10.1007/s001340050286

K. Garey, M. Rege, M. Pai, D. Mingo, K. Suda et al., Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi???Institutional Study, Clinical Infectious Diseases, vol.1, issue.1, pp.25-31, 2006.
DOI : 10.1099/jmm.0.45856-0

M. Morrell, V. Fraser, and M. Kollef, Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, pp.3640-3645, 2005.
DOI : 10.1128/AAC.49.9.3640-3645.2005

P. Massanet, B. Jung, N. Molinari, M. Villiet, V. Moulaire et al., Traitements antifongiques en r??animation au cours des infections fongiques invasives document??es ou suspect??es, Traitements antifongiques en réanimation au cours des infections fongiques invasives documentées ou suspectées, pp.232-241, 2014.
DOI : 10.1016/j.annfar.2014.02.016

B. Segal, N. Almyroudis, M. Battiwalla, R. Herbrecht, J. Perfect et al., Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts, Clinical Infectious Diseases, vol.39, issue.9, pp.402-411, 2007.
DOI : 10.1086/421953

O. Leroy, J. Mira, P. Montravers, J. Gangneux, F. Gouin et al., Candidoses invasives en r??animation??: analyse des traitements antifongiques au cours de l???enqu??te fran??aise AmarCand, Annales Fran??aises d'Anesth??sie et de R??animation, vol.27, issue.12, pp.999-1007, 2008.
DOI : 10.1016/j.annfar.2008.10.004

J. Brajtburg, W. Powderly, G. Kobayashi, and G. Medoff, Amphotericin B: current understanding of mechanisms of action., Antimicrobial Agents and Chemotherapy, vol.34, issue.2, p.183, 1990.
DOI : 10.1128/AAC.34.2.183

É. Dannaoui, R??sistance des Candida aux antifongiques : d??tection et m??canismes, Revue Francophone des Laboratoires, vol.2013, issue.450, pp.71-78, 2013.
DOI : 10.1016/S1773-035X(13)71948-8

A. Vermes, H. Guchelaar, and J. Dankert, Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions, Journal of Antimicrobial Chemotherapy, vol.46, issue.2, pp.171-180, 2000.
DOI : 10.1093/jac/46.2.171

T. Noël, Le point sur les m??canismes de r??sistance aux antifongiques azol??s chez les levures Candida, Journal de Mycologie M??dicale, vol.22, issue.1, p.96, 2012.
DOI : 10.1016/j.mycmed.2011.12.003

A. Datry and E. Bart-delabesse, La caspofungine??: du m??canisme d'action aux applications th??rapeutiques, La Revue de M??decine Interne, vol.27, issue.1, pp.32-41, 2006.
DOI : 10.1016/j.revmed.2005.05.012

L. Bihan, C. Jung, B. Bourgeois, N. Mahul, M. Conseil et al., Apport de la s??rologie Candida dans le bilan pr??-transplantation h??patique, Annales Fran??aises d'Anesth??sie et de R??animation, vol.33, issue.2, pp.110-111, 2014.
DOI : 10.1016/j.annfar.2014.07.183

. Agence-de-la-biomédecine, En ligne]. (consulté le 9 mars 2015) Disponible sur

F. Persat and S. Ranque, Intérêts et limites du sérodiagnostic fongique, Lett Infect. févrTome XXIV, issue.1, pp.8-18, 2009.

D. Aubert, D. Puygauthier-toubas, P. Leon, B. Pignon, F. Foudrinier et al., Characterization of specific anti-Candida IgM, IgA and IgE: diagnostic value in deepseated infections, Mycoses. juin, vol.39, pp.5-6169, 1996.

M. Arendrup, S. Sulim, A. Holm, L. Nielsen, S. Nielsen et al., Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia, Journal of Clinical Microbiology, vol.49, issue.9, pp.3300-3308, 2011.
DOI : 10.1128/JCM.00179-11

P. Eggimann, J. Garbino, and D. Pittet, Epidemiology of Candida species infections in critically ill non-immunosuppressed patients, The Lancet Infectious Diseases, vol.3, issue.11, pp.685-702, 2003.
DOI : 10.1016/S1473-3099(03)00801-6

R. Textoris and L. , La profondeur et la durée de la lymphopénie sont associées à la survenue d'infection nosocomiale chez le traumatisé grave, 42ème Congrès de SRLF -2014 -Paris [En ligne]. (consulté le 26 févr 2015) Disponible sur

D. Horn, D. Neofytos, E. Anaissie, J. Fishman, W. Steinbach et al., Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry, Clinical Infectious Diseases, vol.48, issue.12, pp.1695-703, 2009.
DOI : 10.1086/599039

O. Lortholary, M. Desnos-ollivier, K. Sitbon, A. Fontanet, S. Bretagne et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, pp.532-540, 2011.
DOI : 10.1128/AAC.01128-10

G. Bodey, M. Mardani, H. Hanna, M. Boktour, J. Abbas et al., The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer, The American Journal of Medicine, vol.112, issue.5, pp.380-385, 2002.
DOI : 10.1016/S0002-9343(01)01130-5

G. Chamilos, M. Luna, R. Lewis, G. Bodey, R. Chemaly et al., Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period, Haematologica. juill, vol.91, issue.7, pp.986-995, 1989.

M. Nguyen, M. Wissel, R. Shields, M. Salomoni, B. Hao et al., Performance of Candida Real-time Polymerase Chain Reaction, ??-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis, Clinical Infectious Diseases, vol.59, issue.4, pp.1240-1248, 2012.
DOI : 10.1016/j.diagmicrobio.2007.07.001

M. Prella, J. Bille, M. Pugnale, B. Duvoisin, M. Cavassini et al., Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies, Diagnostic Microbiology and Infectious Disease, vol.51, issue.2, pp.95-101, 2005.
DOI : 10.1016/j.diagmicrobio.2004.08.015

B. Sendid, J. Poirot, M. Tabouret, A. Bonnin, D. Caillot et al., Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species, Journal of Medical Microbiology, vol.51, issue.5, pp.433-475, 2002.
DOI : 10.1099/0022-1317-51-5-433

M. Ellis, B. Al-ramadi, R. Bernsen, J. Kristensen, H. Alizadeh et al., Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever, Journal of Medical Microbiology, vol.15, issue.3, pp.606-621, 2009.
DOI : 10.1128/CMR.15.3.465-484.2002

S. Oliveri, L. Trovato, P. Betta, M. Romeo, and G. Nicoletti, Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients, Clinical Microbiology and Infection, vol.14, issue.4, pp.391-394, 2008.
DOI : 10.1111/j.1469-0691.2007.01938.x

P. Herent, D. Stynen, F. Hernando, J. Fruit, and D. Poulain, Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis

F. Lunel, J. Donnelly, H. Van-der-lee, N. Blijlevens, and P. Verweij, Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy, Medical Mycology, vol.48, issue.8, pp.848-55, 2011.
DOI : 10.1086/596757

V. Lunel, F. Donnelly, J. Van-der-lee, H. A. Blijlevens, N. Verweij et al., Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy, Clinical Microbiology and Infection, vol.15, issue.4, pp.380-386, 2009.
DOI : 10.1111/j.1469-0691.2008.02654.x

D. Rimek, J. Singh, and R. Kappe, Cross-Reactivity of the PLATELIA CANDIDA Antigen Detection Enzyme Immunoassay with Fungal Antigen Extracts, Journal of Clinical Microbiology, vol.41, issue.7, pp.3395-3403, 2003.
DOI : 10.1128/JCM.41.7.3395-3398.2003

E. Werle, R. Kappe, W. Fiehn, and H. Sonntag, [Detection of anti-Candida antibodies of the classes IgM, IgG and IgA using enzyme immunoassay in sequential serum samples of hospitalized patients], Mycoses, vol.37, issue.1, pp.71-79, 1994.

V. Lunel, F. Mennink-kersten, M. Ruegebrink, D. Van-der-lee, H. Donnelly et al., Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy, Diagnostic Microbiology and Infectious Disease, vol.64, issue.4, pp.408-423, 2009.
DOI : 10.1016/j.diagmicrobio.2009.04.012

B. Chumpitazi, B. Lebeau, O. Faure, R. Hamidfar-roy, P. Pavese et al., ??valuation de l???antig??n??mie Candida dans le diagnostic biologique de la candidose chez les patients hospitalises au CHU de Grenoble, Journal de Mycologie M??dicale, vol.22, issue.3, pp.286-293, 2012.
DOI : 10.1016/j.mycmed.2012.07.041

F. Persat, R. Topenot, M. Piens, A. Thiebaut, E. Dannaoui et al., Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis, Mycoses, vol.24, issue.Suppl., pp.11-12455, 2002.
DOI : 10.1016/0277-5379(88)90059-4